HHS is reconsidering whether to implement a 340B Rebate Model Pilot Program consistent with its statutory authority. HRSA issued a Request for Information (RFI) to gather input from interested …

Mar 26, 2026 · Experts discuss the 340B Pricing Program, sharing updates, ongoing challenges, and solutions for pharmacists.

The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities …

Nov 24, 2025 · Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations …

What Is the 340B Program? The 340B Drug Pricing Program was created in 1992, and it is codified as Section 340B of the Public Health Services Act.

340B Health represents more than 1,400 public and private nonprofit hospitals and health systems that participate in the 340B drug pricing program.

Aug 6, 2025 · Enacted in 1992, the 340B Drug Pricing Program requires drug manufacturers to provide significant price discounts on outpatient drugs purchased by certain federal government grantees.

Mar 16, 2026 · See updates on the 340B rebate model, OPPS drug cost survey, and federal and state legislation. Over the past five years, the 340B Drug Pricing Program has been the subject of scrutiny …

Medicare makes changes to the reimbursement and coverage of prescription drugs on an annual basis. The Health Resources and Services Administration (HRSA) administers the 340B Drug Pricing …

Mar 24, 2026 · 340B program growth: Spending by covered entities on 340B drug purchases rose from $ 66 billion in 2023 to $81 billion in 2024. Drivers of growth include increased prices, use of high-cost …